Clinical Trials on Carcinoma Prostate in Russian Federation
Total 653 results
-
PfizerTerminatedNon-Small Cell Lung Cancer | Urothelial CancerKorea, Republic of, United States, Taiwan, Poland, Spain, Russian Federation, Italy, Hungary
-
Sophiris Bio CorpCompletedBenign Prostatic HyperplasiaUnited States, Australia, Canada, Russian Federation, Ukraine, New Zealand
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, France, Germany, Russian Federation, Poland, Italy
-
SanofiCompletedNon-small Cell Lung CancerFrance, Romania, Poland, Croatia, Korea, Republic of, Italy, Chile, United States, Australia, Germany, Russian Federation, Serbia, Ukraine
-
Eisai Inc.Active, not recruitingCarcinoma, HepatocellularUnited States, Spain, United Kingdom, Australia, Sweden, Italy, Austria, Germany, Portugal, Russian Federation
-
AstraZenecaCompletedNon-Small Cell Lung CancerItaly, Spain, France, Korea, Republic of, Hungary, Japan, China, Taiwan, Hong Kong, Germany, Russian Federation
-
TularikTerminatedHepatocellular CarcinomaUnited States, Russian Federation, United Kingdom, Singapore, Thailand, Ukraine, Brazil, China, Poland, Puerto Rico, South Africa
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced or Metastatic Non-Small Cell Lung CancerUnited States, Australia, Brazil, Czech Republic, Russian Federation, Singapore
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCPoland, Taiwan, Thailand, Vietnam, United States, Korea, Republic of, Hungary, Russian Federation, Turkey, China, Australia, Netherlands
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Renal Cell CarcinomaUnited States, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom
-
SanofiActive, not recruitingBreast Cancer Metastatic | Pancreatic Carcinoma MetastaticSpain, Korea, Republic of, Turkey, Chile, Netherlands, Russian Federation, Taiwan, United States, Argentina, Hungary
-
BioNumerik Pharmaceuticals, Inc.Crown BioscienceCompletedOvarian CancerPoland, Russian Federation, Romania, Hungary, Lithuania
-
Oncolytics BiotechCompletedCarcinoma, Squamous Cell of the Head and NeckUnited States, Canada, Spain, Belgium, United Kingdom, Greece, Germany, Hungary, Poland, Slovenia, France, Italy, Russian Federation
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellUnited States, Estonia, France, Korea, Republic of, United Kingdom, Germany, Japan, Russian Federation, Poland
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaBulgaria, Czechia, Germany, Latvia, Russian Federation, Ukraine
-
BayerCompletedCarcinoma, HepatocellularJapan, China, Slovakia, Croatia, France, Hungary, Indonesia, Korea, Republic of, Malaysia, Singapore, Spain, Sweden, Thailand, Philippines, Colombia, Czech Republic, Hong Kong, Italy, Kazakhstan, Mexico, Romania, Russian Federation, Ukrain... and more
-
Glycotope GmbHCompletedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Epithelial Cancer RecurrentGermany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Astellas Pharma Europe B.V.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaBelgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
-
AbbVie (prior sponsor, Abbott)BiogenCompletedOvarian Cancer, Primary Peritoneal CancerUnited States, Australia, Belgium, Italy, Poland, Russian Federation, Spain, Sweden, Switzerland
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaUnited States, Belgium, Germany, Italy, Korea, Republic of, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Byondis B.V.CompletedEndometrial CancerKorea, Republic of, Singapore, Russian Federation, Ukraine, United States, Poland, Serbia
-
AstraZenecaParexelWithdrawnNon Small Cell Lung CancerItaly, Russian Federation, Spain, China, Netherlands, United States, Taiwan, France, Germany
-
GlaxoSmithKlineMerck Sharp & Dohme LLCTerminatedNeoplasms, Head and NeckUnited States, Argentina, Italy, Spain, Belgium, Denmark, Poland, Canada, Germany, Korea, Republic of, Ireland, Japan, United Kingdom, Romania, Hungary, Australia, France, Brazil, Sweden, Russian Federation
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesUnited States, Spain, Belgium, France, Germany, Italy, Korea, Republic of, Turkey, Hungary, Netherlands, Serbia, Poland, Russian Federation, Sweden, Moldova, Republic of, Denmark, Ukraine
-
Genzyme, a Sanofi CompanyActive, not recruitingMedullary Thyroid Cancer | Locally Advanced or Metastatic Medullary Thyroid CancerAustralia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Denmark, Finland, Germany, Greece, India, Israel, Italy, Korea, Republic of, Poland, Russian Federation, Sweden, United Kingdom
-
Jounce Therapeutics, Inc.TerminatedNSCLCLatvia, Bosnia and Herzegovina, Russian Federation, Romania, Turkey, Belarus, Bulgaria, Croatia, Hungary, Serbia, Slovakia, Ukraine, Georgia, Moldova, Republic of
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
CEL-SCI CorporationTeva Branded Pharmaceutical Products R&D, Inc.; Orient Europharma Co., Ltd.CompletedSquamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Soft PalateSpain, Taiwan, United States, United Kingdom, Romania, India, Croatia, Belarus, Hungary, Bosnia and Herzegovina, Russian Federation, Austria, Canada, France, Israel, Italy, Malaysia, Poland, Serbia, Sri Lanka, Thailand, Turkey, Ukraine
-
Bristol-Myers SquibbNektar TherapeuticsCompletedRenal Cell CarcinomaUnited States, Argentina, Brazil, Canada, France, Germany, Mexico, Russian Federation
-
SanofiCompletedOvarian Cancer RecurrentBelgium, Russian Federation, Poland, Spain, Czech Republic, United States, France, Germany, Italy, Ukraine
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CarcinomaFrance, United States, Korea, Republic of, Belgium, Taiwan, Turkey, Russian Federation, Spain, Italy, United Kingdom, Brazil, Belarus, Poland
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Renal Cell CarcinomaUnited States, Argentina, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
Peregrine PharmaceuticalsCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, India, Georgia, Russian Federation, Ukraine
-
AmgenTerminatedAdenocarcinoma of the Pancreas | Locally Advanced | UnresectableSpain, Belgium, Denmark, Poland, United States, Korea, Republic of, Russian Federation, Austria, Portugal, United Kingdom, Germany, Hungary, Czech Republic
-
Hoffmann-La RocheCompletedOvarian CancerFrance, Spain, Brazil, United Kingdom, Netherlands, Italy, Russian Federation, Sweden, Norway
-
Eli Lilly and CompanyCompletedA Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung CancerNon-Small Cell Lung Cancer Stage IVUnited States, Italy, Spain, Australia, France, Germany, Hungary, Korea, Republic of, Poland, Romania, Russian Federation, Taiwan, Ukraine
-
Hoffmann-La RocheCompletedNon-Small-Cell Lung CarcinomaUnited States, Spain, France, Italy, Belgium, Korea, Republic of, Taiwan, United Kingdom, Luxembourg, Australia, Netherlands, Germany, Singapore, Denmark, Russian Federation, Sweden
-
PfizerCompletedNSCLC | SCCHN | Part 1 | MELANOMA | OVCA | SARCOMA | OTHER SOLID TUMORS | Part 1 and 2 | UROTHELIAL CARCINOMAUnited States, Korea, Republic of, Russian Federation, Poland, Malaysia, Bulgaria, Ukraine
-
Immatics Biotechnologies GmbHCompletedMetastatic Renal Cell CarcinomaUnited States, France, Romania, United Kingdom, Italy, Russian Federation, Poland, Germany, Hungary, Netherlands, Norway
-
Genta IncorporatedNational Cancer Institute (NCI)UnknownLung CancerUnited States, Canada, Russian Federation
-
Mateon TherapeuticsTerminatedAnaplastic Thyroid CancerUnited States, India, Belarus, Bulgaria, Egypt, Israel, Italy, Poland, Romania, Russian Federation, Ukraine, United Kingdom
-
GenmabCompletedHead and Neck Cancer | Squamous Cell CancerSweden, United Kingdom, France, Hungary, Canada, Brazil, Belgium, Lithuania, Russian Federation, Serbia, Estonia, Poland
-
AstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, Taiwan, India, Mexico, Russian Federation, Turkey, China, Korea, Republic of, Philippines, Hong Kong
-
PfizerTerminatedOvarian CancerKorea, Republic of, United States, Singapore, Taiwan, Japan, Italy, Australia, Belgium, Ireland, Russian Federation
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Prostatic HyperplasiaFrance, Poland, Germany, Spain, Finland, Netherlands, Russian Federation, Czech Republic, Hungary, Norway, Denmark, Slovakia, Sweden, Austria, Portugal, United Kingdom
-
Bristol-Myers SquibbCompletedCarcinoma, Non-Small-Cell Lung | Small Cell Lung Cancer | Lung CancerUnited States, India, Italy, France, Germany, Poland, Russian Federation, Ukraine
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerAustralia, Belgium, France, Italy, Hong Kong, Canada, Denmark, Taiwan, Russian Federation, United Kingdom, Spain, Hungary, Czech Republic, Poland, Germany, Netherlands
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
Hoffmann-La RocheCompletedProstatic Neoplasms, Castration-ResistantUnited States, Korea, Republic of, Belgium, United Kingdom, Canada, China, Denmark, France, Greece, Poland, Spain, Italy, Czechia, Japan, Switzerland, Australia, Germany, Austria, Hungary, Russian Federation, Taiwan